Gene · 11096
Papers3,260
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 3,260
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| RNA-binding proteins that are highly expressed and enriched in healthy cartilage but suppressed in osteoarthritis. | Front Cell Dev Biol | 2023 | 37457300 | PubTator, text mining | PubMed |
| REST, RCOR1 and RCOR2 expression is reduced in osteoarthritic chondrocytes and contributes to increasing MMP13 and ADAMTS5 expression through upregulating HES1. | Cell Signal | 2023 | 37442513 | PubTator, text mining | PubMed |
| CircSFMBT2-OA alleviates chondrocyte apoptosis and extracellular matrix degradation through repressing NF-κB/NLRP3 inflammasome activation. | Heliyon | 2023 | 37441407 | PubTator, text mining | PubMed |
| NOS inhibition reverses TLR2-induced chondrocyte dysfunction and attenuates age-related osteoarthritis. | Proc Natl Acad Sci U S A | 2023 | 37428931 | PubTator, text mining | PubMed |
| Mesenchymal stromal cells for bone trauma, defects, and disease: Considerations for manufacturing, clinical translation, and effective treatments. | Bone Rep | 2023 | 37425195 | PubTator, text mining | PubMed |
| Targeting macrophagic PIM-1 alleviates osteoarthritis by inhibiting NLRP3 inflammasome activation via suppressing mitochondrial ROS/Cl- efflux signaling pathway. | J Transl Med | 2023 | 37422640 | PubTator, text mining | PubMed |
| Potential pathological and molecular mechanisms of temporomandibular joint osteoarthritis. | J Dent Sci | 2023 | 37404608 | PubTator, text mining | PubMed |
| CC chemokines and receptors in osteoarthritis: new insights and potential targets. | Arthritis Res Ther | 2023 | 37400871 | PubTator, text mining | PubMed |
| Emerging diversity in extracellular vesicles and their roles in cancer. | Front Oncol | 2023 | 37397375 | PubTator, text mining | PubMed |
| Hyperplastic Human Macromass Cartilage for Joint Regeneration. | Adv Sci (Weinh) | 2023 | 37395375 | PubTator, text mining | PubMed |
| CircTBX5 knockdown modulates the miR-558/MyD88 axis to alleviate IL-1β-induced inflammation, apoptosis and extracellular matrix degradation in chondrocytes via inactivating the NF-κB signaling. | J Orthop Surg Res | 2023 | 37393232 | PubTator, text mining | PubMed |
| Cartilage-Related Collagens in Osteoarthritis and Rheumatoid Arthritis: From Pathogenesis to Therapeutics. | Int J Mol Sci | 2023 | 37372989 | PubTator, text mining | PubMed |
| ADAMTS Proteases: Importance in Animal Reproduction. | Genes (Basel) | 2023 | 37372361 | PubTator, text mining | PubMed |
| Medical Prospect of Melatonin in the Intervertebral Disc Degeneration through Inhibiting M1-Type Macrophage Polarization via SIRT1/Notch Signaling Pathway. | Biomedicines | 2023 | 37371708 | PubTator, text mining | PubMed |
| Identification of Novel Diagnostic and Prognostic Gene Signature Biomarkers for Breast Cancer Using Artificial Intelligence and Machine Learning Assisted Transcriptomics Analysis. | Cancers (Basel) | 2023 | 37370847 | PubTator, text mining | PubMed |
| Engineered extracellular vesicles as therapeutics of degenerative orthopedic diseases. | Front Bioeng Biotechnol | 2023 | 37362216 | PubTator, text mining | PubMed |
| Elucidating the role of ubiquitination and deubiquitination in osteoarthritis progression. | Front Immunol | 2023 | 37359559 | PubTator, text mining | PubMed |
| An Atlas of the Knee Joint Proteins and Their Role in Osteoarthritis Defined by Literature Mining. | Mol Cell Proteomics | 2023 | 37356495 | PubTator, text mining | PubMed |
| Synergetic enrichment of aggrecan in nucleus pulposus cells by scAAV6-shRNA-mediated knockdown of aggrecanase-1 and aggrecanase-2. | Exp Biol Med (Maywood) | 2023 | 37354087 | PubTator, text mining | PubMed |
| ROR1/STAT3 positive feedback loop facilitates cartilage degeneration in Osteoarthritis through activation of NF-κB signaling pathway. | Int Immunopharmacol | 2023 | 37343369 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/11096/papers?page=20